Induction Immunotherapy in Elderly Kidney Transplant Recipients - Comparison between Alemtuzumab, Thymoglobulin and Basiliximab Induction Agents Long-Term Outcomes.

被引：0
|
作者：
Zachariah, M. [1 ]
Nader, N. [1 ]
Shah, S. [1 ]
Kandakurti, K. [1 ]
Venuto, R. [1 ]
Pankewycz, O. [1 ]
Laftavi, M. [1 ]
机构：
[1] SUNY Buffalo, Buffalo, NY 14260 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2012年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
985
引用
收藏
页码：315 / 315
页数：1
相关论文
共 50 条
  • [1] Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: Comparison with basiliximab induction - Long-term results
    Kaufman, DB
    Leventhal, JR
    Axelrod, D
    Gallon, LG
    Parker, MA
    Stuart, FP
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (10) : 2539 - 2548
  • [2] Kidney transplant outcomes with alemtuzumab and thymoglobulin induction.
    Bunnapradist, Suphamai
    Gill, Jagbir
    Takemoto, Steven
    Shah, Tariq
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 215 - 215
  • [3] Thymoglobulin Induction in HIV Positive Kidney Transplant Recipients: Report on Transplant and HIV Outcomes.
    Gibney, E.
    Ommert, T.
    Cross, R.
    Ray, A.
    Lizcano, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 329 - 330
  • [4] LONG-TERM OUTCOMES OF INDUCTION THERAPIES WITH ALEMTUZUMAB, BASILIXIMAB OR METHYLPREDNISOLONE IN KIDNEY TRANSPLANT PATIENTS WITH DELAYED GRAFT FUNCTION
    Zhang, A.
    Teran, F.
    Zhang, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (02) : 640 - 640
  • [5] Poor Outcomes in Elderly Kidney Transplant Recipients Receiving Alemtuzumab Induction
    Hurst, Frank P.
    Altieri, Maria
    Nee, Robert
    Agodoa, Lawrence Y.
    Abbott, Kevin C.
    Jindal, Rahul M.
    AMERICAN JOURNAL OF NEPHROLOGY, 2011, 34 (06) : 534 - 541
  • [6] Comparison of Alemtuzumab Versus Basiliximab Induction Therapy in Elderly Kidney Transplant Recipients: A Single-Center Experience
    Yakubu, Idris
    Ravichandran, Bharath
    Sparkes, Tracy
    Barth, Rolf N.
    Haririan, Abdolreza
    Masters, Brian
    JOURNAL OF PHARMACY PRACTICE, 2021, 34 (02) : 199 - 206
  • [7] Outcomes of Basiliximab and Rapid Steroid Withdrawal versus Thymoglobulin Induction in Pediatric Kidney Transplant Recipients
    Steinman, Benjamin
    Kilduff, Stella
    Hayde, Nicole
    PEDIATRIC TRANSPLANTATION, 2023, 27
  • [8] Long Term Outcomes of Induction Therapies with Alemtuzumab, Basiliximab or Methylprednisolone in Kidney Transplant Patients with Delayed Graft Function
    Zhang, Allen
    Paramesh, Anil
    Killackey, Mary
    Buell, Joseph
    Zhang, Rubin
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 86 - 86
  • [9] Induction therapy with basiliximab versus thymoglobulin in African-American kidney transplant recipients
    Haririan, A
    Morawski, K
    Sillix, DH
    El-Amm, JM
    Garnick, J
    West, MS
    Granger, DK
    Migdal, SD
    Gruber, SA
    TRANSPLANTATION, 2005, 79 (06) : 716 - 721
  • [10] Incidence of Infectious Complications in Kidney Transplant Recipients Receiving Induction with Basiliximab, Thymoglobulin or Both
    Jankovic, J.
    Pascual, M.
    Venetz, J. -P.
    Nseir, G.
    Meylan, P.
    Manuel, O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 323 - 323
12345